Δημοσιεύσεις Ερευνητικό Έργο

  1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021 Feb;79(2):243-262.
    Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, et al.
  2. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2021 Feb;79(2):263-282.
    Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, et al.
  3. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol. 2019 Dec;76(6):790-813.
    Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell’Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, et al.
  4. Imaging modalities and treatment of paediatric upper tract urolithiasis: A systematic review and update on behalf of the EAU urolithiasis guidelines panel. J Pediatr Urol. 2020 Oct;16(5):612-624.
    Grivas N, Thomas K, Drake T, et al.
  5. Pelvic lymph node distribution and metastases of prostate and bladder cancer: a systematic literature review and template proposal. World J Urol. 2020 Jun 3. doi: 10.1007/s00345-020-03281-1.
    Grivas N, van den Bergh RCN, Brouwer OR, KleinJan GH, Ramirez-Backhaus M, Wilthagen EA, van der Poel HG.
  6. Re: Vinayak G. Wagaskar, Ankur Mittal, Stanislaw Sobotka, et al. Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.044. Eur Urol. 2021 Feb 26:S0302-2838(21)00146-9.
    Grivas N, Dell’Oglio P, De Groote R, Turri F, Mamoulakis C, Larcher A; J-ERUS YAU Robotic Urology Working Group.
  7. First Report of Two Cases of Acute Gastric Ischemia after Robot-Assisted Radical Cystectomy. Case Rep Urol. 2021 Jan 27;2021:6697689.
    Grivas N, Horsch AD, Wit E, Bruining A, van Sandick J, van der Poel HG.
  8. Diagnostic Value, Oncological Outcomes And Safety Profile Of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy For Prostate Cancer. J Nucl Med. 2021 Feb 5:jnumed.120.259788.
    Mazzone E, Dell’Oglio P, Grivas N, Wit E, Donswijk M, Briganti A, van Leeuwen F, van der Poel H.
  9. Re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). Eur Urol Focus. 2020 Dec 24:S2405-4569(20)30305-9.
    Grivas N, Goonewardene S, Everaerts W, Kalampokis N; J-ERUS/YAU Robotic Urology Working Group.
  10. The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer. Gland Surg. 2020 Aug;9(4):1080-1081.
    Kalampokis N, Grivas N.
  11. Radical Cystectomy in Female Patients – Improving Outcomes. Curr Urol Rep. 2019 Nov 28;20(12):83. doi: 10.1007/s11934-019-0951-z. Review.
    Kalampokis N, Grivas N, Ölschläger M, Hassan FN, Gakis G.
  12. The increasing incidence of immigration and information-seeking behaviour of medical doctors in north-western Greece. Rural Remote Health. 2020 Mar;20(1):4877.
    Bazoukis X, Kalampokis N, Papoudou-Bai A, Bazoukis G, Grivas N.
  13. The Effect of PDE5 Inhibitors on the Male Reproductive Tract. Curr Pharm Des. 2020 Feb 26.
    Sofikitis N, Kaltsas A, Dimitriadis F, Rassweiler J, Grivas N, et al.
  14. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions. J Robot Surg. 2020 Feb;14(1):211-219. doi: 10.1007/s11701-019-00965-8.
    De Groote R, Decaestecker K, Larcher A, Buelens S, De Bleser E, D’Hondt F, Schatteman P, Lumen N, Montorsi F, Mottrie A, De Naeyer G; YAU Robotic and Urothelial Group.
  15. Robot-assisted versus open partial nephrectomy: comparison of outcomes. A systematic review. Minerva Urol Nefrol. 2019 Apr;71(2):113-120. doi: 10.23736/S0393-2249.19.03391-5. Epub 2019 Mar 18.
    Grivas N, Kalampokis N, Larcher A, Tyritzis S, Rha KH, Ficarra V, Buffi N, Ploumidis A, Autorino R, Porpiglia F, van der Poel H, Mottrie A, de Naeyer G; J-ERUS/YAU Robotic Urology Working Group.
  16. The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer. World J Urol. 2019 Aug;37(8):1485-1490. doi: 10.1007/s00345-019-02677-y. Epub 2019 Feb 20.
    van der Poel H, Grivas N, van Leeuwen P, Heijmink S, Schoots I.
  17. Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand? Urol Ann. 2019 Jan-Mar;11(1):115-116. doi: 10.4103/0974-7796.250549.
    Grivas NK.
  18. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. Eur Urol. 2019 Apr;75(4):699-702. doi: 10.1016/j.eururo.2018.11.009. Epub 2018 Nov 22.
    Lam TBL, MacLennan S, Plass K, Willemse PM, Mason MD, Cornford P, Donaldson J, Davis NF, Dell’Oglio P, Fankhauser C, Grivas N, et al.
  19. Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up. J Clin Lab Anal. 2019 Feb;33(2):e22693. doi: 10.1002/jcla.22693
    Grivas N, de Bruin D, Barwari K, van Muilekom E, Tillier C, van Leeuwen PJ, Wit E,
    Kroese W, van der Poel H.
  20. Comprehensive Assessment of Indocyanine Green Usage: One Tracer, Multiple Urological Applications. Eur Urol Focus. 2018 Sep;4(5):665-668. doi: 10.1016/j.euf.2018.08.017. Epub 2018 Sep 7. Review.
    van der Poel HG, Grivas N, van Leeuwen F.
  21. Towards an individualized approach for predicting post-prostatectomy urinary incontinence: the role of nerve preservation and urethral stump length. BJU Int. 2018 Sep;122(3):354-355. doi: 10.1111/bju.14205.
    van der Poel HG, Grivas N.
  22. Robot-assisted extended lymphadenectomy in prostate cancer. Minerva Chir. 2019 Feb;74(1):88-96. doi: 10.23736/S0026-4733.18.07780-5. Epub 2018 Jul 23 Tyritzis SI, Kalampokis N, Grivas N, van der Poel H, Wiklund NP.
  23. The value of periprostatic fascia thickness and fascia preservation as prognostic factors of erectile function after nerve-sparing robot-assisted radical prostatectomy. World J Urol. 2019 Feb;37(2):309-315. doi: 10.1007/s00345-018-2387-3. Epub 2018 Jun 23. Grivas N, van der Roest RC, de Korne CM, et al
  24. Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology. Eur J Radiol. 2018 Jan;98:107-112
    Grivas N, Hinnen K, de Jong J, et al.
  25. Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT Imaging. J Urol. 2018 Jun;199(6):1426-1432.
    Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, et al.
  26. Should we expand the indications for varicocele treatment? Transl Androl Urol. 2017 Oct;6(5):931-942. doi: 10.21037/tau.2017.08.01. Review.
    Vakalopoulos I, Kampantais S, Lymperi S, Grivas N, et al
  27. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2213-2226. doi: 10.1007/s00259-017-3788-z.
    Grivas N, Wit E, Tillier C, van Muilekom E, Pos F, Winter A, van der Poel H.
  28. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy. J Nucl Med. 2018 Feb;59(2):204-209. doi: 10.2967/jnumed.117.195644. Epub 2017 Jul 26
    Grivas N, Wit EMK, Kuusk T, et al.
  29. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer. Urology. 2017 Sep;107:196-201. doi: 10.1016/j.urology.2017.05.047. Epub 2017 Jun 7
    Grivas N, van der Roest R, Tillier C, et al.
  30. Quantitative assessment of fascia preservation improves the prediction of membranous urethral length and inner levator distance on continence outcome after robot-assisted radical prostatectomy. Neurourol Urodyn. 2018 Jan;37(1):417-425. doi: 10.1002/nau.23318. Epub 2017 Jun 6.
    Grivas N, van der Roest R, Schouten D, et al.
  31. What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review. Eur Urol. 2017 Nov;72(5):772-786. doi: 10.1016/j.eururo.2017.04.016.
    Drake T, Grivas N, Dabestani S, et al.
  32. Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer. Angiogenesis. 2017 May;20(2):205-215. doi: 10.1007/s10456-017-9550-0.
    Kuusk T, Albiges L, Escudier B, Grivas N, et al.
  33. Long-term Survival After Resection of Sentinel Node Metastatic Renal Cell Carcinoma.
    Urology. 2017 May;103:e5-e6. doi: 10.1016/j.urology.2017.02.012
    Kuusk T, De Jong J, Grivas N, Horenblas S, Bex A.
  34. The current management of renal cell carcinoma. Minerva Med. 2017 Aug;108(4):357-369. doi: 10.23736/S0026-4806.17.05058-3. Epub 2017 Feb 7. Review.
    Kuusk T, Grivas N, de Bruijn R, Bex A.
  35. Vesico-urethral anastomosis (VUA) evaluation short and long term outcome after robot-assisted laparoscopic radical prostatectomy (RARP): selective cystogram to improve outcome.
    J Robot Surg. 2017 Dec;11(4):441-446. doi: 10.1007/s11701-017-0677-1. Epub 2017 Jan 12
    Tillier C, van Muilekom HA, Bloos-van der Hulst J, Grivas N, van der Poel HG.
  36. Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
    Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):347-354.
    Grivas N, Wit E, Pos F, de Jong J, et al.
  37. Sentinel node biopsy and lymphatic mapping in penile and prostate cancer.
    Urologe A. 2017 Jan;56(1):13-17.
    van der Poel HG, Meershoek P, Grivas N, KleinJan G, van Leeuwen FW, Horenblas S.
  38. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy.
    Eur Urol. 2016 Sep 14. pii: S0302-2838(16)30617-0. [Epub ahead of print]
    Wit EM, Acar C, Grivas N, et al.
  39. Edιtorial Comment
    UROLOGY 2016;95:149-50.
    Grivas N
  40. Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer.
    Cent European J Urol. 2016;69(1):63-71.
    Grivas N, Goussia A, Stefanou D, Giannakis D.
  41. The Efficacy of Medical Expulsive Therapy (MET) in Improving Stone-Free Rate and Stone Expulsion Time, after Extracorporeal Shock Wave Lithotripsy (SWL) for Upper Urinary Stones: a Systematic Review and Meta-Analysis.
    Urology. 2015 Sep 14. pii: S0090-4295(15)00874-2. doi: [Epub ahead of print]
    Skolarikos A, Grivas N, Kallidonis P, Mourmouris P, et al.
  42. The role of nifedipine as medical expulsive therapy (MET) after extracorporeal shockwave lithotripsy (ESWL): A systematic review and meta-analysis.
    Eur Urol Suppl 2015; 14: e1386
    Grivas N., Skolarikos A., Venetis C.,et aL
  43. Editorial Comment
    Urology. 2015; 85: 1110
    Grivas N
  44. Penile lichen sclerosus: An enigmatic and challenging disease.
    Urol Ann. 2015; 7: 308-9
    Grivas N
  45. The role of α-blockers as medical expulsive therapy (MET) after extracorporeal shockwave lithotripsy (ESWL): A systematic review and meta-analysis
    Eur Urol Suppl, 2015; 14 : e390
    Grivas N, Skolarikos A, Venetis C, et al.
  46. Challenges in the diagnosis of xanthogranulomatous cystitis.
    Urol Ann. 2014; 6:375-6
    Grivas N
  47. Highest serial Ki67 expression as an independent prognostic marker of the progression of Non Muscle Invasive Bladder Cancer (NMIBC)
    Eur Urol Suppl, 2014; 13: e1463
    N. Grivas, A. Stratis, G. Kotopoulos, N. Kalampokis, I. Tsimaris, V. Kafarakis, K. Hastazeris, N. Stavropoulos NE
  48. The effectiveness of Otis urethrotomy combined with six weekly urethral dilations until 40 F in the treatment of bladder outlet obstruction in women: A prospective study.
    Urol J 2014; 10:1063-6
    Grivas N, Tsimaris I, Makatsori A, Hastazeris K, Kafarakis V, Stavropoulos NE.
  49. Efficacy of postoperative bladder irrigation with water for injection in reducing recurrence rates of non muscle invasive bladder cancer.
    Asian Pac J Cancer Prev 2014; 15: 2263-6.
    Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Aspiotis S, Stratis A, Stavropoulos NE.
  50. Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece.
    Urol Ann 2014; 6: 116-21.
    Grivas N, Kafarakis V, Tsimaris I, Raptis P, Hastazeris K, Stavropoulos NE.
  51. Neutrophil to Lymphocyte Ratio as an Independent Prognostic Factor in Nonmetastatic Renal Cell Carcinoma
    Eur Urol Suppl 2013; 12; e1376
    Grivas N, Kafarakis V, Tsimaris I, Aspiotis S, Raptis P, Stratis A, Hastazeris K, Stavropoulos N.
  52. Follicular thyroid cancer metastasis to the urinary bladder: Report of a case and review of the literature.
    Case Reports in Urology, vol. 2012, Article ID 178915, 2 pages, 2012.doi:10.1155/2012/178915
    Grivas N, Z. Housianitis, M. Doukas, and N. E. Stavropoulos
  53. Prostate Cancer Epidemiology in a Rural Area of North Western Greece
    Asian Pac J Cancer Prev 2012; 13: 1-4
    Grivas N, K Hastazeris, V Kafarakis et al.
  54. Neutrophil to Lymphocyte Ratio as an Independent Prognostic Factor in Nonmetastatic Renal Cell Carcinoma
    UROLOGY 2013; 82 (3 Supplement 1): S237
    Grivas N, Kafarakis V, Tsimaris I, Aspiotis S, Raptis P, Stratis A, Hastazeris K, Stavropoulos N.
  55. Angiogenesis Comparison between BPH and Prostate Cancer Using Immunohistochemical Methods
    UROLOGY 2012; 80 (Supplement 3A): S214
    Grivas N, Gousia A, Stefanou D, Giannakis D

Κριτής (Reviewer) στα παρακάτω διεθνή περιοδικά

  • European Urology®
  • European Urology Oncology®
  • European Urology Focus®
  • European Urology Open access®
  • The Journal of Urology®
  • BJUI®
  • International Journal of Urology®
  • Clinical Genitourinary Cancer®
  • Urologia Internationalis®
  • Urology Journal®
  • Urology Annals®
  • Central European Journal of Urology®
  • BMC Urology®
  • International Brazilian Journal of Urology
  • Journal of Urology and Research
  • PLOSOne
  • Open Access Journal of Urology & Nephrology
  • Global Journal of Cancer Therapy
  • International Journal of Preventive Medicine
  • SM Journal of Urology

Editorial Board

  • Global Journal of Cancer Therapy
  • International Journal of Clinical Research and Trials
  • Case reports in Internal Medicine
  • International Journal of Nephrology Research
  • Clinics in Oncology
  • Austin Journal of Urology
  • Gavin Journal of Urology and Renal Diseases
  • Urology Updates